Back to discover
Disease
Coronary Aneurysm
Late-stage therapeutic developmentEmerging research
2
Publications
3
Clinical trials
2
Related conditions
2024
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2023-11-20Arthritis & rheumatology (Hoboken, N.J.)
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 1 clinical trial with recent milestones (1 completed or reporting results).
Major developments
Major trial resultsHigh impact
Results posted2026-06-03
Clinical MilestonesViewHide
Results posted
Activity timeline1
- 2026-06-03ClinicalPhase 2 Study to Assess the Efficacy and Safety of Doxycycline in Preventing Coronary Artery Aneurysm Formation and ProgressionResults posted
Clinical trials
The current development programme across all trial phases.
Clinical programme
3
1
1
2
Late-stage studies
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20042024
Most influential
Recent publications
Major themes3
- Coronary Aneurysm1
- Mucocutaneous Lymph Node Syndrome1
- Systemic Inflammatory Response Syndrome1
Leading journals2
- Arthritis & rheumatology (Hoboken, N.J.)1
- Circulation1
Leading researchers8
- Newburger JW2
- Baddour LM1
- Baker A1
- Baltimore RS1
- Bolger AF1
- Brodeur KE1
- Burns JC1
- Chang JC1
Affiliations (unnormalised)2
- Boston Children's Hospital1
- Boston Children's Hospital and Brigham and Women's Hospital1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Abnormal balloon- or sac-like dilatation in the wall of CORONARY VESSELS. Most coronary aneurysms are due to CORONARY ATHEROSCLEROSIS, and the rest are due to inflammatory diseases, such as KAWASAKI DISEASE.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.